Travere Therapeutics, Inc. financial data

Symbol
TVTX on Nasdaq
Industry
Pharmaceutical Preparations
Location
3611 Valley Centre Dr, Suite 300, San Diego, CA
State of incorporation
CA
Fiscal year end
December 31
Former names
Retrophin, Inc. (to 11/13/2020), Desert Gateway, Inc. (to 2/19/2013)
Latest financial report
10-K - Q4 2024 - Feb 21, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 232 % -44.7%
Quick Ratio 19.6 % +106%
Debt-to-equity 1.86K % +515%
Return On Equity -1.09K % -1826%
Return On Assets -55.6 % -295%
Operating Margin -139 % +48%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 88.7M shares +16.6%
Common Stock, Shares, Outstanding 87.5M shares +16%
Entity Public Float 624M USD -45.5%
Common Stock, Value, Issued 9K USD +28.6%
Weighted Average Number of Shares Outstanding, Basic 78.9M shares +6.22%
Weighted Average Number of Shares Outstanding, Diluted 78.9M shares +6.22%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 233M USD +60.5%
Research and Development Expense 7.5M USD
Costs and Expenses 557M USD +4.43%
Operating Income (Loss) -324M USD +16.6%
Nonoperating Income (Expense) 3.32M USD -72.4%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -321M USD +14.8%
Income Tax Expense (Benefit) 120K USD -46.2%
Net Income (Loss) Attributable to Parent -322M USD -189%
Earnings Per Share, Basic -4.08 USD/shares -153%
Earnings Per Share, Diluted -4.08 USD/shares -153%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 58.5M USD +0.62%
Accounts Receivable, after Allowance for Credit Loss, Current 27.1M USD +28%
Inventory, Net 6.2M USD -34.1%
Assets, Current 417M USD -32.4%
Property, Plant and Equipment, Net 5.34M USD -28.7%
Operating Lease, Right-of-Use Asset 14.3M USD -20.9%
Intangible Assets, Net (Excluding Goodwill) 104M USD -0.45%
Goodwill 800K USD 0%
Other Assets, Noncurrent 18.2M USD +70.4%
Assets 594M USD -24.7%
Accounts Payable, Current 23.5M USD -43.5%
Accrued Liabilities, Current 86M USD -27.7%
Contract with Customer, Liability, Current 2.82M USD -60.3%
Liabilities, Current 201M USD +12.8%
Contract with Customer, Liability, Noncurrent 0 USD -100%
Operating Lease, Liability, Noncurrent 17.2M USD -24%
Other Liabilities, Noncurrent 6.8M USD -34.1%
Liabilities 535M USD -9.02%
Accumulated Other Comprehensive Income (Loss), Net of Tax -80K USD +94.5%
Retained Earnings (Accumulated Deficit) -1.45B USD -28.6%
Stockholders' Equity Attributable to Parent 59.1M USD -70.6%
Liabilities and Equity 594M USD -24.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -119M USD -46.7%
Net Cash Provided by (Used in) Financing Activities -525K USD -100%
Net Cash Provided by (Used in) Investing Activities 105M USD
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 87.5M shares +16%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -14.9M USD -115%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 58.5M USD +0.62%
Deferred Tax Assets, Valuation Allowance 344M USD +18.4%
Deferred Tax Assets, Gross 349M USD +17.6%
Operating Lease, Liability 22.6M USD -17.9%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -320M USD -191%
Lessee, Operating Lease, Liability, to be Paid 25.4M USD -20.4%
Property, Plant and Equipment, Gross 14.1M USD -5.57%
Operating Lease, Liability, Current 5.41M USD +10.1%
Lessee, Operating Lease, Liability, to be Paid, Year Two 6.89M USD +3.24%
Lessee, Operating Lease, Liability, to be Paid, Year One 6.67M USD +2.52%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 2.8M USD -36.1%
Lessee, Operating Lease, Liability, to be Paid, Year Three 7.06M USD +2.54%
Deferred Tax Assets, Operating Loss Carryforwards 113M USD +39%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 20M shares 0%
Unrecognized Tax Benefits 27.4M USD +19.6%
Lessee, Operating Lease, Liability, to be Paid, Year Four 4.78M USD -32.3%
Additional Paid in Capital 1.51B USD +13.4%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 41.7M USD +15%
Depreciation, Depletion and Amortization 9.88M USD +49.2%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Share-based Payment Arrangement, Expense 36.9M USD -16.6%
Interest Expense 11.2M USD -1.75%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%